R3 Vascular
PrivateLast Round
Series B
May 9, 2024
Total Funding Raised
$104.8M
Momentum Score
50 /100
Company Overview
R3 Vascular Inc. is a privately-held medical device company focused on developing and commercializing a novel technology platform for fully bioresorbable, sirolimus-coated vascular scaffolds. These scaffolds are designed to treat peripheral arterial disease (PAD), particularly in below-the-knee (BTK) applications. The company's MAGNITUDE® scaffold is made from a unique, ultra-high molecular weight polylactic acid polymer, which allows the device to be thinner, stronger, and more flexible while providing stent-like support and the anti-inflammatory benefits of sirolimus. The scaffold is engineered to be gradually and predictably absorbed into the tissue, leaving behind a more naturally functioning vessel. In May 2024, the company secured $87 million in a Series B financing round to support its ELITE FDA IDE pivotal trial and prepare for commercialization.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices
Business Model
B2B
Customer Profile
Hardware Sales
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
R3 Vascular Comps
Public and private peers based on sector, stage, and business model.
R3 Vascular Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | May 9, 2024 | ||||
| Series A | Oct 8, 2020 |
R3 Vascular Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Deerfield Management | Series B |
| 415 | Series A, Series B |
| 415 Capital | Series B, Series A |
| Wexford Capital | Series A |
| HBM-MedFocus Funds | Series A |
R3 Vascular Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about R3 Vascular's valuation, stock price, and market status.
